These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11709363)
1. Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro. Kamau SW; Grimm F; Hehl AB Antimicrob Agents Chemother; 2001 Dec; 45(12):3654-6. PubMed ID: 11709363 [TBL] [Abstract][Full Text] [Related]
2. Leishmania infantum promastigotes: flow cytometry as a possible tool for assessing the effects of drugs on cellular functions. Azas N; Di Giorgio C; Delmas F; Gasquet M; Timon-David P Exp Parasitol; 1997 Sep; 87(1):1-7. PubMed ID: 9287952 [TBL] [Abstract][Full Text] [Related]
3. Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. Savoia D; Scutera S; Raimondo S; Conti S; Magliani W; Polonelli L Exp Parasitol; 2006 Jul; 113(3):186-92. PubMed ID: 16487518 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometry analysis of the effect of allopurinol and the dinitroaniline compound (Chloralin) on the viability and proliferation of Leishmania infantum promastigotes. Kamau SW; Nunez R; Grimm F BMC Pharmacol; 2001; 1():1. PubMed ID: 11299045 [TBL] [Abstract][Full Text] [Related]
5. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes. Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261 [TBL] [Abstract][Full Text] [Related]
6. Short report: fluorescent Leishmania: application to anti-leishmanial drug testing. Singh N; Dube A Am J Trop Med Hyg; 2004 Oct; 71(4):400-2. PubMed ID: 15516633 [TBL] [Abstract][Full Text] [Related]
7. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes. Khademvatan S; Adibpour N; Eskandari A; Rezaee S; Hashemitabar M; Rahim F Exp Parasitol; 2013 Oct; 135(2):208-16. PubMed ID: 23872452 [TBL] [Abstract][Full Text] [Related]
8. Antileishmanial Activity of New Synthesized Schiff and Mannich (Morpholine) Base Compounds. Direkel Ş; Ünver Y; Akdemir C Turkiye Parazitol Derg; 2020 Dec; 44(4):216-220. PubMed ID: 33269563 [TBL] [Abstract][Full Text] [Related]
9. Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5'-(3'-phenylisoxazolino)methyl]-8-hydroxyquinoline: preliminary study. Dardari Z; Lemrani M; Bahloul A; Sebban A; Hassar M; Kitane S; Berrada M; Boudouma M Farmaco; 2004 Mar; 59(3):195-9. PubMed ID: 14987982 [TBL] [Abstract][Full Text] [Related]
10. Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity. Scala A; Cordaro M; Grassi G; Piperno A; Barberi G; Cascio A; Risitano F Bioorg Med Chem; 2014 Feb; 22(3):1063-9. PubMed ID: 24433962 [TBL] [Abstract][Full Text] [Related]
11. Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum. Mesquita JT; Pinto EG; Taniwaki NN; Galisteo AJ; Tempone AG Acta Trop; 2013 Dec; 128(3):666-73. PubMed ID: 24071379 [TBL] [Abstract][Full Text] [Related]
12. In vitro antileishmanial activity of trans-stilbene and terphenyl compounds. Castelli G; Bruno F; Vitale F; Roberti M; Colomba C; Giacomini E; Guidotti L; Cascio A; Tolomeo M Exp Parasitol; 2016 Jul; 166():1-9. PubMed ID: 26953250 [TBL] [Abstract][Full Text] [Related]
13. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs. Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751 [TBL] [Abstract][Full Text] [Related]
14. Selenocyanates and diselenides: a new class of potent antileishmanial agents. Plano D; Baquedano Y; Moreno-Mateos D; Font M; Jiménez-Ruiz A; Palop JA; Sanmartín C Eur J Med Chem; 2011 Aug; 46(8):3315-23. PubMed ID: 21571403 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum. González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives. Delmas F; Avellaneda A; Di Giorgio C; Robin M; De Clercq E; Timon-David P; Galy JP Eur J Med Chem; 2004 Aug; 39(8):685-90. PubMed ID: 15276301 [TBL] [Abstract][Full Text] [Related]
17. GC-MS analysis and antileishmanial activities of two Turkish propolis types. Duran N; Muz M; Culha G; Duran G; Ozer B Parasitol Res; 2011 Jan; 108(1):95-105. PubMed ID: 20842509 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Di Giorgio C; Delmas F; Ollivier E; Elias R; Balansard G; Timon-David P Exp Parasitol; 2004; 106(3-4):67-74. PubMed ID: 15172213 [TBL] [Abstract][Full Text] [Related]
19. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect. Prada CF; Alvarez-Velilla R; Balaña-Fouce R; Prieto C; Calvo-Álvarez E; Escudero-Martínez JM; Requena JM; Ordóñez C; Desideri A; Pérez-Pertejo Y; Reguera RM Biochem Pharmacol; 2013 May; 85(10):1433-40. PubMed ID: 23466420 [TBL] [Abstract][Full Text] [Related]
20. Activity of melatonin against Leishmania infantum promastigotes by mitochondrial dependent pathway. Elmahallawy EK; Jiménez-Aranda A; Martínez AS; Rodriguez-Granger J; Navarro-Alarcón M; Gutiérrez-Fernández J; Agil A Chem Biol Interact; 2014 Sep; 220():84-93. PubMed ID: 24973643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]